# Baxter Oncology GmbH – FDA Inspection, May 3, 2023

Source: https://www.keypedia.com/records/fda_inspections/baxter-oncology-gmbh/49ff9f86-3d55-44a7-abeb-1a0511f483b6
Source feed: FDA_Inspections

> FDA inspection 1206312 of Baxter Oncology GmbH, May 03, 2023. Classification: No Action Indicated (NAI). 11 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1206312
- Company Name: Baxter Oncology GmbH
- Inspection Date: 2023-05-03
- Classification: No Action Indicated (NAI)
- Classification Code: NAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 0

## Related Documents

- [FDA Inspection 1283802 - 2025-09-26](https://www.keypedia.com/records/fda_inspections/baxter-oncology-gmbh/d2cc3497-33d6-41da-be71-fed681081e29)
- [FDA Inspection 1249702 - 2024-08-27](https://www.keypedia.com/records/fda_inspections/baxter-oncology-gmbh/8f606d21-cc2a-4cf4-813d-420b7e93dccc)
- FDA Inspection 1161093 - 2020-01-29
- FDA Inspection 1106642 - 2019-09-03
- [FDA Inspection 1056958 - 2018-06-14](https://www.keypedia.com/records/fda_inspections/baxter-oncology-gmbh/9da172d1-9118-487f-b26d-5b064e49e5f1)

## Related Officers

- [FDA Associated Person](https://www.keypedia.com/people/santiago-gallardo-johnson/f5086b0c-c8fc-44dd-8d12-6506b9dd313f)

Company: https://www.keypedia.com/companies/baxter-oncology-gmbh/43dd5bdb-ca73-4678-ba1f-6ef4b5400e06

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c